Reporting and Recordkeeping Requirements Related to Suspicious Orders

ICR 202012-1117-001

OMB: 1117-0056

Federal Form Document

Forms and Documents
IC Document Collections
ICR Details
202012-1117-001
Received in OIRA
DOJ/DEA
Reporting and Recordkeeping Requirements Related to Suspicious Orders
New collection (Request for a new OMB Control Number)   No
Regular 12/08/2020
  Requested Previously Approved
36 Months From Approved
338,840 0
90,357 0
4,740,372 0

This new information collection is related to the reporting of orders received under suspicious circumstances (ORUSCs). DEA implements and enforces titles II and III of the Comprehensive Drug Abuse Prevention and Control Act of 1970, Pub. L. No. 91-513, 84 Stat. 1242 (1970), as amended (collectively, the CSA). 21 U.S.C. 801–971. The CSA requires registrants to design and operate a system to disclose to the registrant suspicious orders of controlled substances, i.e., orders of unusual size, orders deviating from a normal pattern, and orders of unusual frequency. Registrants are also required to “inform the Field Division Office of the Administration in his area of suspicious orders when discovered by the registrant.” The collection would include two distinct components: the reporting of suspicious orders, and recordkeeping related to suspicious orders and ORUSCs. The collection would be applicable to registrants that distribute controlled substances, including manufacturers, distributors, importers, and pharmacies (and other practitioners in certain cases). Registrants would be required to file suspicious order reports through DEA's centralized database. Each report must contain: the DEA registration number of the registrant placing the order for controlled substances; the date the order was received; the DEA registration number of the registrant making the report; the National Drug Code number, unit, dosage strength, and quantity of the controlled substances ordered; the order form number for schedule I and schedule II controlled substances; the unique transaction identification number for the suspicious order; and what information and circumstances rendered the order actually suspicious.

US Code: 21 USC 801-971 Name of Law: The Controlled Substances Act
   PL: Pub.L. 115 - 271 3291, 3292 Name of Law: The Preventing Drug Diversion Act of 2018
  
PL: Pub.L. 115 - 271 3291-3292 Name of Law: The Preventing Drug Diversion Act of 2018

1117-AB47 Proposed rulemaking 85 FR 69282 11/02/2020

No

1
IC Title Form No. Form Name
Reporting and Recordkeeping Requirements Related to Suspicious Orders Not Applicable Suspicious Orders of Controlled Substances Database

  Total Request Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 338,840 0 0 338,840 0 0
Annual Time Burden (Hours) 90,357 0 0 90,357 0 0
Annual Cost Burden (Dollars) 4,740,372 0 0 4,740,372 0 0
Yes
Changing Regulations
No
This is a new information collection. Therefore there is not a previous burden to compare it to.

No
    Yes
    Yes
No
No
No
No
Danielle Staley 571 203-8530 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
12/08/2020


© 2024 OMB.report | Privacy Policy